1. Papa ND, Gambini D, Meroni PL. Anti-endothelial ceil antibodies and autoimmune diseases. Clin Rew Allergy 12:275–2861994.
4. Heurkens AHM, Hiemstra PS, Lafeber GJM, Daha MR, Breedveld FC. Anti-endothelial cell antibodies in rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol 78:7–121989.
5. Leung DYM, Havens PL, Moake JL, Kim M, Pober JS. Lytic anti-endothelial cell antibodies in hemolytic uremic syndrome. Lancet 2:183–1861988.
6. Yap HK, Sakai RS, Bahn L, Rappaport V, Woo KT, Ananthurman V, Lim CH, Chiang GSC, Jordan SC. Anti-endothelial cell antibodies in patients with IgA nephropathy; frequency and clinical significance. Clin Immunol Immunopathol 29:450–4621988.
7. Joyce S, Flye MW, Mohanakumar T. Characterisation of kidney cell-specific, non major histocompatibility complex alloantigen using antibodies eluted from rejected human renal allografts. Transplantation 46:362–3691988.
8. Karrupan SS, Tyden G, Reinhilt F, Berg U, Moller E. Hyperacute rejection of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transplant Immunol 5:321–3271997.
9. Cerilli J, Holliday JE, Fesperman DP, Folger MA. Antivascular endothelial antibody- its role in transplantation. Surgery 81:132–1381977.
10. Clarke JL, Brasile L, Rhoades J, Thompson JS, Cerilli J. Serologic comparison anti-granulocyte and anti-VEC cytotoxicity of human myelomonocytic antigen (HMMA) and vascular endothelial cell system (VEC). Transplant Proc 21:647–6541989.
11. Miltemberg AMM, Meijr-Paape ME, Weenning JJ, Daha MR, van Es LA, van der Woude FJ. Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation. Transplantation 48:681–6881989.
12. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Magdi HY. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 339:1566–15701992.
13. Tixier D, Tuso P, Czer L, Yasunaga C, Tyan D, Fishbein M, Admon D, Barath P, Blanche C, Cramer DV, Makowka L, Trento A. Characterization of antiendothelial cell and anti heart antibodies following heart transplantation. Transplant Proc 25:931–9341993.
14. Fredrich R, Toyoda M, Lawrence SC, Czer L, Galfayan K, Galera O, Trento A, Freimark D, Young S, Jordan SC. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 67:385–3911999.
15. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Hayry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfillippo F, Verani R, Von Willebrand E, Yamaguchi Y. International standardization of criteria for the histological diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411–4221993.
17. Williams GM, Ter Haar A, Park LC, Krajewski CA. Endothelial changes associated with hyperacute, acute and chronic renal allograft rejection in man. Transplant Proc 5:819–8221973.
18. Perrey C, Brenchley PEC, Johnson RWG, Martin S. An association between antibodies specific for endothelial cells and renal transplant failure. Transplant Immunol 5:321–3271997.
19. Al-Hussen KA, Talbot D, Proud G, Taylor RMR, Shenton BK. The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transpl Int 8:214–2201995.
20. Brasile L, Rodman E, Shield CF III, Clarke J, Cerilli J. The association of antivascular endothelial cell antibody with hyperacute rejection: a case report. Surgery 99:637–6391986.
21. Moraes JR, Stastny P. Human endothelial cell antigens. Molecular independence from HLA and expression in blood monocytes. Transplnat Proc 9:605–6071977.
22. Gohra H, McDonald TO, Verrier ED, Aziz S. Endothelial loss and regeneration in a model of transplant arteriosclerosis. Transplantation 60:96–1021995.
23. Beekhuizen H, van de Gevel JS. Endothelial cell adhesion molecules in inflammation and postischemic reperfusion injury. Transplant Proc 30:4251–42561988.
25. Raska K, Raskova J, Shea SM, Frankel RM, Wood RH, Lifter J, Ghobrial I, Eisinger RP, Homer L. T cell subsets and cellular immunity in end-stage renal disease. Am J Med 75:734–7401983.
26. Beaurain G, Naret C, Marcon L, Grateau G, Drueke T, Urena P, Nelson DL, Bach JF, Chatenaud L. In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients. Kidney Int 32:84–881987.
27. Remuzzi G, Rossi EC. Effect of renal failure on granulocytes: Hematologic consequences of renal failure. In: Brenner BM, ed. Brenner and Rector’s the kidney. 5th ed. 2178–2180Philadelphia: W.B. Saunders, 1996.
28. Perkins DL, Carpenter CB. Graft rejection: Immunobiology of transplantation. In: Brenner BM, ed. Brenner and Rector’s the kidney. 5th ed. 2590–2593Philadelphia: W.B. Saunders, 1996.